Lv11
20 积分 2023-11-03 加入
P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE AS INDUCTION THERAPY FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH HIGH-RISK CYTOGENETICS: A SUBGROUP ANALYSIS FROM THE GMMG-HD7 TRIAL
22分钟前
求助中
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study
38分钟前
已完结
Isatuximab in Combination with Lenalidomide and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma: Updated Safety Run-in Results from the Randomized Phase 3 Ithaca Study
4个月前
已关闭
Isatuximab Plus Pomalidomide/Low-Dose Dexamethasone Versus Pomalidomide/Low-Dose Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (ICARIA-MM): Characterization of Subsequent Antimyeloma Therapies
4个月前
已关闭
Phase III (IMROZ) study design: Isatuximab plus bortezomib (V), lenalidomide (R), and dexamethasone (d) vs VRd in transplant-ineligible patients (pts) with newly diagnosed multiple myeloma (NDMM)
4个月前
已关闭
Atomically Dispersed Supported Metal Catalysts: Seeing Is Believing
10个月前
已完结
Greatly Enhanced Electrocatalytic N2 Reduction on TiO2 via V Doping
10个月前
已完结
Novel reduced graphene oxide-supported Cd0.5Zn0.5S/g-C3N4 Z-scheme heterojunction photocatalyst for enhanced hydrogen evolution
10个月前
已完结
Unveiling Interfacial Effects for Efficient and Stable Hydrogen Evolution Reaction on Ruthenium Nanoparticles‐Embedded Pentlandite Composites
10个月前
已完结
皖公网安备34019202002308
